Home » Topics » Regulatory

Regulatory
RSS

BTG licenses analgesic combination to Forest

Sep. 6, 1996

FDA approves two pain products from Mallinckrodt

Sep. 6, 1996

Serostim FDA-approved for cachexia in AIDS patients

Aug. 30, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996

Tegretol-XR launched in U.S.

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

BMS, Sano to collaborate on transdermal BuSpar development

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...